Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan MaiJi Biotechnology is a high-tech enterprise specializing in the research, development, and manufacturing of molecular diagnostic reagents and automated laboratory instruments. Based in Changsha, China, the company focuses on providing comprehensive solutions for infectious disease detection, including COVID-19, human papillomavirus (HPV), and tuberculosis. Their core technology platform utilizes advanced fluorescence quantitative PCR and rapid nucleic acid extraction methods to ensure high sensitivity and specificity. MaiJi Biotechnology operates GMP-certified facilities and holds international certifications such as ISO 13485 and CE marks for its product portfolio. The company serves a wide range of clinical and public health institutions, contributing to improved diagnostic accuracy and patient management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan MaiJi Biotechnology.